NCM
CPIX icon

Next Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Next Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40
Closed – – 373
2019
Q2 		$0 Buy
+40
New +$243 ﹤0.01% 848

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Next Capital Management's CPIX Position: Q3 2019 in Review

Next Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2019, closing a stake of 40 shares.

Next Capital Management first reported a position in CPIX in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 28 funds tracked by Wall St. Rank hold CPIX as of Q3 2019.

  • Next Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Next Capital Management sold 40 Cumberland Pharmaceuticals shares in Q3 2019.
  • Next Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Next Capital Management's Cumberland Pharmaceuticals position peaked at $0 in Q2 2019.
  • 28 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.